Polaris DX, a leading smart-tech diagnostics company, has unveiled its latest innovation, the Igloo Pro, a cutting-edge diagnostic device designed to deliver lab-quality blood test results in minutes. This breakthrough technology is set to transform point-of-care testing (POCT) for dental and healthcare professionals, enabling faster, more efficient patient care and improved health outcomes.
The Igloo Pro, developed by DX365 in Germany and manufactured by a high-tech electronics company in Poland, is a universal analysis platform capable of measuring key wellness markers such as Vitamin D, Ferritin (iron deficiency), and CRP (inflammation). These markers are increasingly recognized as critical to optimizing patient outcomes, particularly in dental surgery and oral health.
Timothy Ritson, CEO of Polaris DX, emphasized the growing importance of health diagnostics in dental practices. “Dentists are increasingly analyzing client health indicators, including Vitamin D levels, before undertaking expensive procedures like implants,” he said. “Many people in the UK are deficient in Vitamin D, which is essential for maintaining healthy bones and teeth. Igloo Pro provides dentists with a fast, easy-to-use solution to assess these markers on-site, allowing them to recommend supplements or treatments that can improve patient recovery and reduce surgical failure rates.”
Key Features of Igloo Pro
The Igloo Pro stands out for its unique capabilities, which include:
- On-Site Testing with Lab-Quality Results: The device uses single-use capillary assays to deliver accurate results in minutes, eliminating the need for external lab testing.
- Ease of Use: No specialized training is required; any staff member can be trained to operate the machine, reducing the need for an in-house phlebotomist.
- Enhanced Patient Engagement: By offering on-the-spot testing, healthcare providers can engage patients more effectively and provide immediate recommendations for supplements, products, or treatments.
- New Revenue Streams: Clinics can charge for tests and offer additional services, such as personalized treatment plans, directly to patients during their visit.
Environmental and Operational Benefits
The Igloo Pro also addresses the inefficiencies of the current pathology model in the UK, which is often slow, costly, and environmentally taxing. By enabling rapid on-site testing, the device reduces the need for multiple patient visits and minimizes the environmental impact associated with traditional lab processes.
Moreover, the Igloo Pro is a smart device, equipped with cloud connectivity to the DX365 laboratory. This allows for real-time calibration of new tests, instant software updates, and seamless sharing of patient results via email or messaging. The device also stores patient data, enabling healthcare providers to monitor trends over time and make informed decisions about patient care.
Expanding Capabilities
The Igloo Pro supports a wide range of capillary assays, with an ever-expanding portfolio that includes:
- AMH (Anti-Mullerian Hormone)
- CRP (Inflammation)
- cTnI (Troponin Capillary)
- D-Dimer (Blood Clots/Thrombosis)
- Ferritin (Iron Content)
- FSH (Follicle Stimulating Hormone)
- HbA1c (Diabetes Management)
- LH (Luteinizing Hormone)
- Nab (Neutralizing Antibody)
- Progesterone
- TES (Testosterone)
- TSH (Thyroid Hormone)
- Vitamin D-25 Hydroxyvitamin
This versatility makes the Igloo Pro a valuable tool not only for dentists but also for a wide range of healthcare professionals seeking to provide comprehensive, data-driven care.
A New Era in Diagnostics
The launch of Igloo Pro marks a significant step forward in the evolution of point-of-care testing. By combining speed, accuracy, and ease of use with smart technology, Polaris DX is empowering healthcare providers to deliver better patient outcomes while streamlining their operations. As the demand for rapid, reliable diagnostics continues to grow, devices like the Igloo Pro are poised to play a pivotal role in shaping the future of healthcare.
